Our findings suggest that DLBCL-associated lymphomatous effusions may be associated mechanistically with TP53-MDM2 pathway and HDAC-related chromatin remodeling mechanisms. The gene discussed is MDM2; the disease is diffuse large B-cell lymphoma.